Indivior
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 1.1K
- Market Cap
- $1.6B
- Website
- http://indivior.com
- Introduction
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
SUBLOCADE Shows Promise as Safe Treatment Option for Opioid Use Disorder During Pregnancy
New research indicates monthly buprenorphine depot injection (SUBLOCADE) demonstrates no increased risk of birth defects or maternal complications when used during pregnancy for opioid use disorder treatment.
FDA Delays Review of SUBLOCADE Label Changes for Opioid Use Disorder Treatment
Indivior PLC reports FDA has delayed final review of proposed label changes for SUBLOCADE, their extended-release buprenorphine injection for opioid use disorder treatment.